National Health (Prescriber bag supplies) Amendment Determination 2018 (No. 4) (PB 66 of 2018) (Cth)

Case

PB 66 of 2018

National Health (Prescriber bag supplies) Amendment Determination 2018 (No. 4)

National Health Act 1953

___________________________________________________________________________

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under sections 93 and 93AB of the National Health Act 1953.

Dated 27 JULY 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

  1. Name of Determination

(1)This Determination is the National Health (Prescriber bag supplies) Amendment Determination 2018 (No. 4).

(2)This Determination may also be cited as PB 66 of 2018.

  1. Commencement

This Determination commences on 1 August 2018.

  1. Amendment of National Health (Prescriber bag supplies) Determination 2012

Schedule 1 amends the National Health (Prescriber bag supplies) Determination 2012 (PB 73 of 2012).

Schedule 1  Amendments

  1. Schedule, entry for Atropine

omit from the column headed “Form”:       Injection containing atropine sulfate 600 micrograms in 1 mL

substitute:            Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL

  1. Schedule, entry for Diphtheria and tetanus vaccine, adsorbed, diluted for adult use

omit:

10 Diphtheria and tetanus vaccine, adsorbed, diluted for adult use Injection 0.5 mL MP, NP 10
  1. Schedule, entry for Metoclopramide

omit from the column headed “Form”:       Injection containing metoclopramide hydrochloride 10 mg in 2 mL

substitute:            Injection containing 10 mg metoclopramide hydrochloride (as monohydrate) in 2 mL

  1. Schedule, entry for Morphine

(a)omit from the column headed “Form”:       Injection containing morphine hydrochloride 10 mg in 1 mL

substitute:   Injection containing morphine hydrochloride trihydrate 10 mg in 1 mL

(b)omit from the column headed “Form”:       Injection containing morphine hydrochloride 20 mg in 1 mL

substitute:   Injection containing morphine hydrochloride trihydrate 20 mg in 1 mL

(c)omit from the column headed “Form”:       Injection containing morphine sulfate 15 mg in 1 mL

substitute:   Injection containing morphine sulfate pentahydrate 15 mg in 1 mL

(d)omit from the column headed “Form”:       Injection containing morphine sulfate 30 mg in 1 mL

substitute:   Injection containing morphine sulfate pentahydrate 30 mg in 1 mL

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0